Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry
Public ClinicalTrials.gov record NCT03603275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Assessing Hemophilia A Patient and Physician Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This US study aims to assess hemophilia A patient characteristics and reasons for switching from both patient/caregiver and physician perspectives. For this purpose, this research study will include hemophilia A patients who have switched from an existing therapy to Kovaltry or Jivi. In doing so, real world evidence will be obtained from both patient and physician perspectives offering key insights for effective therapeutic management of patients with hemophilia A and to more fully understand what drives patient switching from a patient perspective and a physician perspective.
Study identification
- NCT ID
- NCT03603275
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 3 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 6, 2018 (Actual)
- Primary completion
- May 14, 2020 (Actual)
- Completion
- May 14, 2020 (Actual)
- Last update posted
- Aug 25, 2022
2018 – 2020
United States locations
- U.S. sites
- 27
- U.S. states
- 22
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, San Diego | La Jolla | California | 92093 | — |
| University of Colorado Denver Hemophilia and Thrombosis Center | Aurora | Colorado | 80045 | — |
| Yale Hemophilia Treatment Center | New Haven | Connecticut | 06510 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Johns Hopkins All Children's Hospital | St. Petersburg | Florida | 33701 | — |
| St. Josephs Hemophilia Treatment Center | Tampa | Florida | 33607 | — |
| Emory / Children's Healthcare of Atlanta | Atlanta | Georgia | 30322 | — |
| Bleeding and Clotting Disorders Institute | Peoria | Illinois | 61615 | — |
| Indiana Hemophilia and Thrombosis Center IHTC | Indianapolis | Indiana | 46260 | — |
| Louisiana Center for Bleeding and Clotting Disorders / Tulane | New Orleans | Louisiana | 70112 | — |
| Maine Hemophilia and Thrombosis Center | Scarborough | Maine | 04074 | — |
| The Johns Hopkins University Hemophilia Treatment Center | Baltimore | Maryland | 21205 | — |
| Boston Hemophilia Center at Children's Hospital of Boston/Brigham Women's | Boston | Massachusetts | 02115 | — |
| Univ of Michigan Hemophilia and Coagulation Disorders | Ann Arbor | Michigan | 48109 | — |
| Michigan State University Center for Bleeding Disorders & Clotting Disorders | East Lansing | Michigan | 48824 | — |
| Children's Mercy Hospital (Kansas City) | Kansas City | Missouri | 64108 | — |
| Dartmouth-Hitchcock Comprehensive Hemophilia and Thrombosis Center | Lebanon | New Hampshire | 03756 | — |
| Weill Cornell Medicine | New York | New York | 10065 | — |
| Mary M. Gooley Hemophilia Center, Inc. | Rochester | New York | 14621 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Children's Hospital of Philadelphia (CHOP) | Philadelphia | Pennsylvania | 01914 | — |
| Penn Comprehensive Hemophilia and Thrombophilia Program / Hospital UPENN | Philadelphia | Pennsylvania | 19104 | — |
| Hemophilia Center of Western Pennsylvania | Pittsburgh | Pennsylvania | 15213 | — |
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | — |
| UT Southwestern/Children's Health Dallas | Dallas | Texas | 75390 | — |
| BloodWorks (Puget Sound) | Seattle | Washington | 98104 | — |
| Blood Center of Wisconsin, Inc. /Childrens Hosp of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03603275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2022 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03603275 live on ClinicalTrials.gov.